L26/P-450 Do large treatment effects differ by country? A meta-epidemiological study of infertility randomized controlled trials
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von B.W. Mol und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What is the prevalence of large treatment effects among infertility randomized controlled trials (RCTs) by country? Summary answer Large treatment effects are frequently reported in infertility RCTs, but only a small proportion are statistically significant, with substantial variation in prevalence across countries. What is known already Large treatment effects reported in randomized controlled trials are uncommon in modern infertility research and may signal selective reporting or concerns about trial trustworthiness. However, the extent to which the prevalence of large treatment effects varies across countries in infertility RCTs has not been systematically examined. Study design, size, duration This is a meta-epidemiological study of infertility RCTs. We systematically searched EMBASE, MEDLINE, and CENTRAL for infertility RCTs published between 1 January 2012, and 30 August 2023 for infertility trials. Trials involving subfertile women that reported contingency tables for biochemical pregnancy, clinical pregnancy, ongoing pregnancy, or live birth were eligible. These outcomes were eligible for inclusion regardless of whether they were specified as primary or secondary outcomes. Participants/materials, setting, methods From each full-text publication, we manually extracted contingency tables for pregnancy and live birth outcomes and recorded the country where participants were recruited. The treatment effect measured by relative risk was computed based on the contingency tables extracted. Large treatment effects were defined as a statistically significant relative risk for pregnancy and/or live birth below 0.80 or above 1.25. Main results and the role of chance Among 8,757 records, we found 1,318 eligible infertility RCTs. China published the highest number of trials (n = 294), followed by Iran (n = 262), Egypt (n = 133), Turkey (n = 80), and India (n = 69). Among 1,318 trials, 55.5% (n = 731) reported large treatment effects, of which 20.0% (n = 263) were statistically significant. Among 587 trials with small treatment effects, 0.85% (n = 5) were statistically significant. Statistically significant large treatment effects were observed in 8.6% (72/841) of trials reporting biochemical pregnancy, 20.1% (237/1,181) of trials reporting clinical pregnancy, 15.2% (52/343) of trials reporting ongoing pregnancy, and 14.4% (68/471) of trials reporting live births. Among countries contributing the largest numbers of clinical trials, the proportion reporting large treatment effects was 55.4% in China, 61.1% in Iran, 60.2% in Egypt, 60.0% in Turkey, and 59.4% in India. Israel had the highest proportion reporting large treatment effects (76.5%, 13/17). Limitations, reasons for caution The definition of large treatment effects was informed by prespecified, knowledge-based thresholds rather than empirically derived cut-offs and may therefore be debated. Wider implications of the findings Substantial cross-country variation in the reporting of large treatment effects suggests that trial results may be influenced by contextual or methodological factors beyond the interventions themselves. This highlights the need for cautious interpretation of trial evidence and for greater emphasis on trial quality, transparency and trustworthiness screening in evidence synthesis. Trial registration number Yes
Zitieren
APA
Mol, B., Feng, Q., Li, W., Crispin, J., Longobardi, S., Hooghe, T. D., & Li, W. (2026). L26/P-450 Do large treatment effects differ by country? A meta-epidemiological study of infertility randomized controlled trials. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.784
Vancouver
Mol B, Feng Q, Li W, Crispin J, Longobardi S, Hooghe TD, et al. L26/P-450 Do large treatment effects differ by country? A meta-epidemiological study of infertility randomized controlled trials. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.784
BibTeX
@article{Mol2026,
author = {Mol, B.W. and Feng, Q. and Li, W. and Crispin, J. and Longobardi, S. and Hooghe, T. D’ and Li, W.},
title = {L26/P-450 Do large treatment effects differ by country? A meta-epidemiological study of infertility randomized controlled trials},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.784}
}
EUVIMED